Neuroprotective efficacy of estrogen in experimental spinal cord injury in rats

Annals of the New York Academy of Sciences

Volumn 1199, Issue , 2010, Pages 90-94

  Samantaray, Supriti ^a   Sribnick, Eric A ^a   Das, Arabinda ^a   Thakore, Nakul P ^a   Matzelle, Denise ^a   Yu, Shan P ^b   Ray, Swapan K ^c   Wei, Ling ^b   Banik, Naren L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Axonal degeneration; Calpain; Estrogen; Neuroprotection; Spinal cord injury

Indexed keywords

ESTROGEN;

ANGIOGENESIS; CONFERENCE PAPER; DRUG EFFICACY; ESTROGEN THERAPY; GLIOSIS; HUMAN; NERVE CELL; NERVE CELL LESION; NERVE FIBER DEGENERATION; NEUROPROTECTION; NONHUMAN; SPINAL CORD INJURY;

RATTUS;

EID: 77954016588     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05357.x     Document Type: Conference Paper

References (30)

1. Spinal Cord Injury: causes. In Spinal Cord Injury, 2009. Mayo Foundation for Medical Education and Research (MFMER).
2. Miller, S.M. 2008. Methylprednisolone in acute spinal cord injury: a tarnished standard. J. Neurosurg. Anesthesiol. 20: 140-142.
3. Rozet, I. 2008. Methylprednisolone in acute spinal cord injury: is there any other ethical choice? J. Neurosurg. Anesthesiol. 20: 137-139.
4. Hadley,M.N. et al. 2002.Guidelines for the management of acute cervical spine and spinal cord injuries. Clin. Neurosurg. 49: 407-498.
5. Faden, A.I. & B. Stoica. 2007. Neuroprotection: challenges and opportunities. Arch. Neurol 64: 794-800.
6. Brann, D.W. et al. 2007. Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids 72: 381-405.
7. Pozzi, S. et al. 2006. Estrogen action in neuroprotection and brain inflammation. Ann. N.Y. Acad. Sci. 1089: 302-323.
8. Simpkins, J.W. & J.A. Dykens. 2008. Mitochondrial mechanisms of estrogen neuroprotection. Brain Res. Rev. 57: 421-430.
9. Sribnick, E.A., et al. 2006. Estrogen treatment of spinal cord injury attenuates calpain activation and apoptosis. J. Neurosci. Res. 84: 1064-1075.
10. Sribnick, E.A. et al. 2005. Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats. J. Neurosci. Res. 82: 283-293.
11. Vasudevan, N. & D.W. Pfaff. 2008.Non-genomic actions of estrogens and their interaction with genomic actions in the brain. Front. Neuroendocrinol. 29: 238-257.
12. Marino,M., P. Galluzzo & P. Ascenzi. 2006. Estrogen signaling multiple pathways to impact gene transcription. Curr. Genomics 7: 497-508.
13. Straub, R.H. 2007. The complex role of estrogens in inflammation. Endocr. Rev. 28: 521-574.
14. Miller, V.M. & S.P. Duckles. 2008. Vascular actions of estrogens: functional implications. Pharmacol. Rev. 60: 210-241.
15. Kelly, M.J. & E.R. Levin. 2001. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol.Metab. 12: 152-156.
16. Nilsen, J. 2008. Estradiol and neurodegenerative oxidative stress. Front. Neuroendocrinol. 29: 463-475.
17. Gustafsson, J.A. 2000. Novel aspects of estrogen action. J. Soc. Gynecol. Invest. 7: S8-S9.
18. Sur, P., et al. 2003. Estrogen attenuates oxidative stressinduced apoptosis in C6 glial cells. Brain Res. 971: 178-188.
19. Sribnick, E.A., S.K. Ray & N.L. Banik. 2006. Estrogen prevents glutamate-induced apoptosis in C6 glioma cells by a receptor-mediated mechanism. Neuroscience 137: 197-209.
20. Sribnick, E.A., et al. 2004. 17β-Estradiol attenuates glutamate-induced apoptosis and preserves electrophysiologic function in primary cortical neurons. J. Neurosci. Res. 76: 688-696.
21. Sribnick, E.A., et al. 2007. Estrogen improves locomotor function following spinal cord injury. J. Neurochem. 102(Suppl 1): 203.
22. Islamov, R.R. et al. 2003. Effect of 17β-estradiol on gene expression in lumbar spinal cord following sciatic nerve crush injury in ovariectomized mice. Brain Res. 966: 65-75.
23. Yune, T.Y. et al. 2004. Systemic administration of 17β- estradiol reduces apoptotic cell death and improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma 21: 293-306.
24. Yune, T.Y. et al. 2008. Estrogen-induced Bcl-2 expression after spinal cord injury is mediated through phosphoinositide-3-kinase/Akt-dependent CREB activation. J. Neurotrauma 25: 1121-1131.
25. Webb, A.A. et al. 2006. Estrogen reduces the severity of autonomic dysfunction in spinal cord-injured male mice. Behav. Brain Res. 171: 338-349.
26. Chaovipoch, P. et al. 2006. 17β-Estradiol is protective in spinal cord injury in post- and pre-menopausal rats. J. Neurotrauma 23: 830-852.
27. Cuzzocrea, S. et al. 2008. Effect of 17β-estradiol on signal transduction pathways and secondary damage in experimental spinal cord trauma. Shock 29: 362-371.
28. Ritz, M.F. & O.N. Hausmann. 2008. Effect of 17β- estradiol on functional outcome, release of cytokines, astrocyte reactivity and inflammatory spreading after spinal cord injury in male rats. Brain Res. 1203: 177-188.
29. Swartz, K.R. et al. 2007. Gender differences in spinal cord injury are not estrogen-dependent. J. Neurotrauma 24: 473-480.
30. Roof, R.L. & E.D. Hall. 2000. Estrogen-related gender difference in survival rate and cortical blood flow after impact-acceleration head injury in rats. J. Neurotrauma 17: 1155-1169.